Aligos Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
ALGS
CUSIP
01626L204
Type
Equity
Class
COM NEW
Num filings
29
Total reported value, excl. options
$14.7 M
Manager Report Date Value ($000) Shares Option Type